欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2019/001
药品名称Alluzience
活性成分
    • botulinum toxin 200.0 U/ml
剂型Solution for injection
上市许可持有人Ipsen Pharma France
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Cyprus (CY)
      Alluzience 200U/ml solution for injection
    • Austria (AT)
      Alluzience 200 Speywood-Einheiten/ml Injektionslösung
    • Estonia (EE)
    • Croatia (HR)
    • Ireland (IE)
    • Lithuania (LT)
      Alluzience 200 V/ml injekcinis tirpalas
    • Malta (MT)
      Alluzience, 200 U solution for injection
    • Iceland (IS)
      Alluzience
    • Latvia (LV)
      Alluzience 200 Speywood vienības/ml šķīdums injekcijām
    • Luxembourg (LU)
    • Poland (PL)
      Alluzience
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Finland (FI)
    • Belgium (BE)
      Alluzience 200 Speywood-eenheden/ml oplossing voor injectie
    • Slovenia (SI)
    • Norway (NO)
      Alluzience
    • Denmark (DK)
      Alluzience
    • Slovakia (SK)
    • Greece (GR)
    • Germany (DE)
      Alluzience
    • Romania (RO)
    • Italy (IT)
    • Spain (ES)
    • Czechia (CZ)
      Alluzience
    • Bulgaria (BG)
      Alluzience
    • France (FR)
      Alluzience
    • Hungary (HU)
      Alluzience (Solution for injection 200 U/ml)
    • Portugal (PT)
许可日期2021/06/10
最近更新日期2025/06/11
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Other
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase